Compugen (CGEN) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2025)
Compugen (CGEN) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Compugen |
189.59 Mn |
97.83 Mn |
352,000.00 |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-164.42% |
| Jun 30, 2025 |
18.73% |
| Sep 30, 2024 |
202.63% |
| Jun 30, 2024 |
-51,592,788.81% |
| Jun 30, 2023 |
-100.00% |
| Jun 30, 2022 |
414.44% |
| Mar 31, 2019 |
-7,101.45% |
| Mar 31, 2018 |
101.16% |
| Dec 31, 2015 |
66.67% |
| Jun 30, 2015 |
-100.00% |
| Dec 31, 2014 |
66.67% |
| Jun 30, 2014 |
22.22% |
| Dec 31, 2013 |
40.00% |
| Sep 30, 2013 |
-20.00% |
| Jun 30, 2013 |
100.00% |
| Dec 31, 2012 |
-50.00% |
| Sep 30, 2012 |
0.00% |
| Dec 31, 2011 |
-44.71% |
| Jun 30, 2010 |
-15,586.42% |
